Making AIDS a business imperative

Lancet. 1999 Jul 3;354(9172):1.
No abstract available

Publication types

  • Editorial

MeSH terms

  • AIDS Vaccines / administration & dosage
  • AIDS Vaccines / economics
  • Acquired Immunodeficiency Syndrome / economics*
  • Acquired Immunodeficiency Syndrome / prevention & control
  • Cost-Benefit Analysis
  • Developing Countries*
  • Health Promotion / economics
  • Humans
  • United Nations

Substances

  • AIDS Vaccines